Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MAFLD criteria overlooks a number of patients with severe steatosis: Is it clinically relevant?

Literature DB >> 32819754

MAFLD criteria overlooks a number of patients with severe steatosis: Is it clinically relevant?

Jiaofeng Huang¹, Rahul Kumar², Mingfang Wang¹, Yueyong Zhu¹, Su Lin³.

Abstract

Entities: Disease Species

Keywords: Metabolic associated fatty liver disease; Metabolic risk; NHANES; Non-alcoholic fatty liver disease

Mesh：

Year: 2020 PMID： 32819754 DOI： 10.1016/j.jhep.2020.06.016

Source DB: PubMed Journal: J Hepatol ISSN： 0168-8278 Impact factor: 25.083

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups.

Authors: Hyoeun Kim; Chan Joo Lee; Byoung Kwon Lee; Seung Up Kim; Jung Il Lee; Sang Hoon Ahn; Kwan Sik Lee; Su Jung Baik
Journal: Dig Dis Sci Date: 2022-05-17 Impact factor: 3.487

2. Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease.

Authors: Yi-Ning Dai; Cheng-Fu Xu; Hong-Ying Pan; Hai-Jun Huang; Mei-Juan Chen; You-Ming Li; Chao-Hui Yu
Journal: World J Clin Cases Date: 2022-05-06 Impact factor: 1.534

3. NAFLD and MAFLD as emerging causes of HCC: A populational study.

Authors: Shuna Myers; Isabelle Neyroud-Caspar; Laurent Spahr; Konstantinos Gkouvatsos; Evelyne Fournier; Emiliano Giostra; Giulia Magini; Jean-Louis Frossard; Marie-Eve Bascaron; Nathalie Vernaz; Lucia Zampaglione; Francesco Negro; Nicolas Goossens
Journal: JHEP Rep Date: 2021-01-19

4. Characterization of microbiome and metabolite analyses in patients with metabolic associated fatty liver disease and type II diabetes mellitus.

Authors: Qiuping Yang; Leisheng Zhang; Qian Li; Man Gu; Qiu Qu; Xinglong Yang; Qinghua Yi; Kunli Gu; Linli Kuang; Mei Hao; Jing Xu; Hongju Yang
Journal: BMC Microbiol Date: 2022-04-15 Impact factor: 4.465

MAFLD criteria overlooks a number of patients with severe steatosis: Is it clinically relevant?

1. MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups.

2. Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease.

3. NAFLD and MAFLD as emerging causes of HCC: A populational study.

4. Characterization of microbiome and metabolite analyses in patients with metabolic associated fatty liver disease and type II diabetes mellitus.

5. Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?

6. NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III.

7. MAFLD in Obese Children: A Challenging Definition.

Review 8. From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights.

9. MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis.